Phase I and II Agents in Cancer Therapy: I. Anthracyclines and Related Compounds-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Phase I and II Agents in Cancer Therapy: I. Anthracyclines and Related Compounds

Published:1986-09-10 Issue:7 Volume:26 Page:491-509
ISSN:0091-2700
Container-title:The Journal of Clinical Pharmacology
language:en
Short-container-title:

Author:

Wadler Scott,Fuks Joachim Z.,Wiernik Peter H.

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/j.1552-4604.1986.tb02942.x/fullpdf

Reference214 articles.

1. Probabilities of eventually developing and dying of cancer in the United States, 1985;Seidman;CA,1985

2. The genetic origin of drug resistance in neoplasms: Implications for systemic therapy;Goldie;Cancer Res,1984

3. Why do cancer cells resist drugs?;Kolata;Science,1985

4. Tumor size, sensitivity to therapy and design of treatment schedules;Norton;Cancer Treat Rep,1977

Cited by 37 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recent Developments of Quinoline-Heterocyclic Conjugates as Anticancer Agents;Egyptian Journal of Chemistry;2022-10-31

2. Mutactimycin AP, a New Mutactimycin Isolated from an Actinobacteria from the Atacama Desert;Molecules;2022-10-24

3. Discovery of New Quinazoline-Based Anticancer Agents as VEGFR-2 Inhibitors and Apoptosis Inducers;Russian Journal of Bioorganic Chemistry;2022-07-04

4. The DNA-topoisomerase Inhibitors in Cancer Therapy;Biomedical and Pharmacology Journal;2022-06-30

5. The Critical Role of 12-Methyl Group of Anthracycline Dutomycin to Its Antiproliferative Activity;Molecules;2022-05-23

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP